Chajec, Don-Siemion & Zyto has advised NanoGroup S.A., an advanced biotech company, on setting up a holding designed to generate added value by tapping into the group’s potential.
According to CDZ, during the first stage of the project the firm developed the group’s concept and drafted the documentation necessary to create the holding’s structure, while, in the second stage, the firm was "responsible for preparing the legal component of a prospectus that was filed with the Polish Financial Supervision Authority on May 23 and is another step towards the company’s listing on the Warsaw Stock Exchange."
NanoGroup consists of three subsidiaries -- NanoVelos S.A., NanoSanguis S.A., and NanoThea S.A. -- all involved in the development of five advanced biotechnological projects. According to NanoGroup President Marek Borzestowsk, “The public offering is being carried out to raise more funds to finance a biotechnological project currently developed by NanoGroup and to finance investment in new projects.”
The CDZ legal team was headed by Partner Maciej Kotlicki and Piotr Rychta, assisted by Malgorzata Sas-Madej, Aleksandra Hulewicz, Daniel Kozlowski, Monika Ciechomska, and Marcin Lizurek.